Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma
Abstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this stu...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-020-78892-0 |
_version_ | 1818570907798470656 |
---|---|
author | Dan Tao Ningning Zhang Qingqing Huang Chuang Ge Qicheng Li Shujie Li Kegui Weng Qishuai Guo Jiangdong Sui Can Wang Xin Zhang Ying Wang |
author_facet | Dan Tao Ningning Zhang Qingqing Huang Chuang Ge Qicheng Li Shujie Li Kegui Weng Qishuai Guo Jiangdong Sui Can Wang Xin Zhang Ying Wang |
author_sort | Dan Tao |
collection | DOAJ |
description | Abstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this study. The association of EBV status with peripheral blood immune cell counts, distant metastases, and long-term survival in patients with advanced NPC were determined. Eighty-seven (59.6%) of all patients were positive for EBV. Compared with patients with normal NK cell count, patients with lower NK cell count showed a significantly lower EBV viral load (median: 614.0 vs. 2190.0 copies/mL, P = 0.024). EBV-positive patients showed a significantly higher incidence of liver metastasis than EBV-negative patients (32.6% vs. 23.7%, P = 0.021). Multi-variant regression analysis showed that EBV infection was independently associated with liver metastasis (OR: 2.33, P = 0.043). EBV positive patients showed a significantly worse PFS (P = 0.001) and OS (P = 0.001) than EBV negative patients. Multivariate Cox regression analysis revealed that EBV infection was independently associated with a worse PFS (HR: 1.94, P = 0.003), and OS (HR: 2.12, P = 0.014) in advanced NPC. In conclusion, EBV infection is associated with a high risk of liver metastasis and is also an independent negative predictor for PFS and OS in patients with advanced NPC. EBV infection is associated with lower CD8% and higher NK%, while lower NK cell count is associated with lower EBV viral load. |
first_indexed | 2024-12-14T13:48:20Z |
format | Article |
id | doaj.art-95716ff752ca4ce8a48065a3d8139afa |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-12-14T13:48:20Z |
publishDate | 2020-12-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-95716ff752ca4ce8a48065a3d8139afa2022-12-21T22:59:15ZengNature PortfolioScientific Reports2045-23222020-12-0110111110.1038/s41598-020-78892-0Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinomaDan Tao0Ningning Zhang1Qingqing Huang2Chuang Ge3Qicheng Li4Shujie Li5Kegui Weng6Qishuai Guo7Jiangdong Sui8Can Wang9Xin Zhang10Ying Wang11Department of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalChongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer HospitalDepartment of Nutrition, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Clinical Laboratory, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalDepartment of Radiation Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer HospitalAbstract The purpose of this study was to investigate the association of Epstein-Barr virus (EBV) with peripheral blood immune cell counts and clinical outcomes in advanced nasopharyngeal carcinoma (NPC) patients. In a retrospective design, 146 patients with NPC at stage IV were enrolled in this study. The association of EBV status with peripheral blood immune cell counts, distant metastases, and long-term survival in patients with advanced NPC were determined. Eighty-seven (59.6%) of all patients were positive for EBV. Compared with patients with normal NK cell count, patients with lower NK cell count showed a significantly lower EBV viral load (median: 614.0 vs. 2190.0 copies/mL, P = 0.024). EBV-positive patients showed a significantly higher incidence of liver metastasis than EBV-negative patients (32.6% vs. 23.7%, P = 0.021). Multi-variant regression analysis showed that EBV infection was independently associated with liver metastasis (OR: 2.33, P = 0.043). EBV positive patients showed a significantly worse PFS (P = 0.001) and OS (P = 0.001) than EBV negative patients. Multivariate Cox regression analysis revealed that EBV infection was independently associated with a worse PFS (HR: 1.94, P = 0.003), and OS (HR: 2.12, P = 0.014) in advanced NPC. In conclusion, EBV infection is associated with a high risk of liver metastasis and is also an independent negative predictor for PFS and OS in patients with advanced NPC. EBV infection is associated with lower CD8% and higher NK%, while lower NK cell count is associated with lower EBV viral load.https://doi.org/10.1038/s41598-020-78892-0 |
spellingShingle | Dan Tao Ningning Zhang Qingqing Huang Chuang Ge Qicheng Li Shujie Li Kegui Weng Qishuai Guo Jiangdong Sui Can Wang Xin Zhang Ying Wang Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma Scientific Reports |
title | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
title_full | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
title_fullStr | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
title_full_unstemmed | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
title_short | Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
title_sort | association of epstein barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma |
url | https://doi.org/10.1038/s41598-020-78892-0 |
work_keys_str_mv | AT dantao associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT ningningzhang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT qingqinghuang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT chuangge associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT qichengli associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT shujieli associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT keguiweng associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT qishuaiguo associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT jiangdongsui associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT canwang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT xinzhang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma AT yingwang associationofepsteinbarrvirusinfectionwithperipheralimmuneparametersandclinicaloutcomeinadvancednasopharyngealcarcinoma |